-
Kenvue Inc. (KVUE $21.34)
- $21.34 P/E (TTM): 38.11X Cap: $42.58B
- View KVUE Profile
- View Questions on KVUE
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Johnson & Johnson (JNJ $173.33)
- $173.33 P/E (TTM): 18.54X Cap: $417.43B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $625.65)
- $625.65 P/E (TTM): 50.91X Cap: $592.15B
- View LLY Profile
- View Questions on LLY
-
Kenvue Inc. (KVUE $21.34)
- $21.34 P/E (TTM): 38.11X Cap: $42.58B
- View KVUE Profile
- View Questions on KVUE
Q: I have held JNJ for years and I am *STILL* holding on , in the [vain] hope that surely management will FINALLY resolve its various self-inflicted legal problems. I have been MISERABLY wrong. JNJ shares continue to decline (drowning is the perception as we focus much more on loss). I was idiot enough to buy into JNJ’s spin off KVUE, on which I have a rather loss in just one year.
Notwithstanding the enthusiasm of media commentators, the health care sector hasn’t done anything outside of a couple of star-companies. Are JNJ and KVUE worth holding on to? I would appreciate very much your substance-backed reasons either way. In your answer, kindly please put less emphasis on the legal issues which are already well known and focus entirely on the future prospects .
Many thanks.
Notwithstanding the enthusiasm of media commentators, the health care sector hasn’t done anything outside of a couple of star-companies. Are JNJ and KVUE worth holding on to? I would appreciate very much your substance-backed reasons either way. In your answer, kindly please put less emphasis on the legal issues which are already well known and focus entirely on the future prospects .
Many thanks.
-
Mondelez International Inc. (MDLZ $61.83)
- $61.83 P/E (TTM): 22.65X Cap: $80B
- View MDLZ Profile
- View Questions on MDLZ
-
Kenvue Inc. (KVUE $21.34)
- $21.34 P/E (TTM): 38.11X Cap: $42.58B
- View KVUE Profile
- View Questions on KVUE
Q: WHICH CONSUMER STOCK MONDELEZ OR KENVUE WOULD BE BETTER NOW AND GOING FORWARD FOR THE FUTURE?
-
Mondelez International Inc. (MDLZ $61.83)
- $61.83 P/E (TTM): 22.65X Cap: $80B
- View MDLZ Profile
- View Questions on MDLZ
-
Kenvue Inc. (KVUE $21.34)
- $21.34 P/E (TTM): 38.11X Cap: $42.58B
- View KVUE Profile
- View Questions on KVUE
Q: MONDELEZ OR KENVUE WHICH ONE WOULD YOU TAKE FOR THE PRESENT AND FUTURE? ALSO, THE REASONS FOR PICKING THE ONE YOU DID?
Insiders
Share Information
SEC Filings
News and Media